Abbott Laboratories (ABT) Revenue (2009 - 2026)

Abbott Laboratories has disclosed Revenue across 18 years of filings, most recently posting $12.6 billion for Q2 2026.

• In Q2 2026, Revenue rose 13.02% year-over-year to $12.6 billion; the TTM figure through Jun 2026 stood at $46.6 billion (up 8.06% YoY), while the FY2025 annual figure was $44.3 billion, up 5.67% from the prior year.
• Revenue came in at $12.6 billion for Q2 2026 at Abbott Laboratories, up from $11.2 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $12.6 billion in Q2 2026 to a low of $9.7 billion in Q1 2023.
• Average Revenue over 5 years is $10.8 billion, with a median of $10.5 billion recorded in 2022.
• Year-over-year, Revenue climbed 13.76% in 2022 and fell 18.06% in 2023.
• Over 5 years, Revenue stood at $10.1 billion in 2022, then increased by 1.49% to $10.2 billion in 2023, then gained by 7.16% to $11.0 billion in 2024, then increased by 4.42% to $11.5 billion in 2025, then advanced by 9.9% to $12.6 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $12.6 billion in Q2 2026, $11.2 billion in Q1 2026, and $11.5 billion in Q4 2025.